genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
News
News
Therapeutic Anticoagulant with No Bleeding Side Effects Reportedly Developed
Cancer
Researchers Unravel Four-Stranded DNA’s Role in Breast Cancer
Coronavirus
U.K. Gets COVID-19 Testing Boost with Oxford Nanopore’s LamPORE
Biomarkers
Immunotherapy Benefits Could Be Determined by ctDNA Test
Coronavirus
COVID-19 Severity Linked to Coagulation Dysfunction and Ancient Branch of Immune…
Insights
All
Trends for 2020
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
August 2020 Vol. 40 No. 8
Fully Automated Luxury Drug Discovery
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
At Orchard, Moving from Pruning to Planting
Cancer
Researchers Unravel Four-Stranded DNA’s Role in Breast Cancer
Coronavirus
U.K. Gets COVID-19 Testing Boost with Oxford Nanopore’s LamPORE
Biomarkers
Immunotherapy Benefits Could Be Determined by ctDNA Test
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Janssen Biotech
Janssen Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Janssen Biotech
J&J’s Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
Janssen Biotech
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Janssen Biotech
J&J Eyes September Trial for COVID-19 Vaccine, Commits to Expanded $1B+ BARDA Partnership
Janssen Biotech
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Janssen Biotech
Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary Treatment by 2025
Janssen Biotech
JLABS, Children’s National to Open Incubator, Collaborate on BARDA “Innovation Zone”...
Janssen Biotech
J&J Innovation Partners with AdoRx Therapeutics on Lung Cancer Treatments
Janssen Biotech
J&J’s Janssen to Develop MeiraGTx’s Retinal Disease Gene Therapies
Janssen Biotech
J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration
Janssen Biotech
Janssen Halts Clinical Studies of Alzheimer’s Candidate
Janssen Biotech
Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M
Janssen Biotech
Janssen to Codevelop Theravance’s TD-1473 in $1B+ Collaboration
Janssen Biotech
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Janssen Biotech
J&J Halts Sirukumab Development, Talacotuzumab Trial
Janssen Biotech
Provention Bio to Develop Two Janssen GI Immunology Candidates
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
